Position in DGX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,717,199
-$461,596 QoQ
Shares Held
12,820
-21.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#341
of 1,090 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $199,150,782 across 8 Diagnostics & Research names. DGX ranks #5 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
653,183 | $124,418,297 | |
| 2 | LH |
Labcorp Holdings Inc.
|
218,731 | $61,244,680 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
18,789 | $4,261,157 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
5,866 | $2,940,977 | |
| 5 | DGX |
Quest Diagnostics Inc
This page
|
12,820 | $2,717,199 | |
| 6 | QGEN |
Qiagen N.V.
|
56,506 | $2,209,384 | |
| 7 | WAT |
Waters Corp /De/
|
2,473 | $927,473 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
815 | $431,615 |
All Filings in DGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,717,199 | 12,820 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,178,795 | 16,220 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,798,518 | 16,127 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,073,483 | 16,127 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,896,893 | 16,127 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,755,591 | 16,286 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,954,542 | 12,956 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,011,419 | 12,956 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,729,615 | 12,636 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,216,092 | 9,136 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,266,427 | 9,185 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $556,290 | 4,565 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $636,034 | 4,525 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $627,039 | 4,432 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $675,351 | 4,317 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $534,192 | 4,354 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $574,074 | 4,317 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $536,080 | 3,917 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $606,746 | 3,507 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $443,340 | 3,051 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $402,640 | 3,051 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $406,196 | 3,165 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||